LMR Partners’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $535K | Sell |
|
|||||
|
2025
Q1 | $1.69M | Sell |
|
|||||
|
2024
Q4 | $3.05M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $3.77M | Buy |
|
|||||
|
2023
Q4 | $1.33M | Sell |
|
|||||
|
2023
Q3 | $7.13M | Buy |
|
|||||
|
2023
Q2 | $1.56M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $2.37M | Sell |
|
|||||
|
2022
Q3 | $7.66M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $6.92M | Buy |
|
|||||
|
2021
Q3 | $5.25M | Sell |
|
|||||
|
2021
Q2 | $13.9M | Buy |
|
|||||
|
2021
Q1 | $3.2M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $43.4M | Sell |
|
|||||
|
2020
Q2 | $59.7M | Sell |
|
|||||
|
2020
Q1 | $53.4M | Buy |
|
|||||
|
2019
Q4 | $34.2K | Sell |
|
|||||
|
2019
Q3 | $43.3M | Sell |
|
|||||
|
2019
Q2 | $80.9M | Buy |
|
|||||
|
2019
Q1 | $28.4M | Buy |
|